Skip to content

Physical activity in the prevention and management of gestational diabetes

Timing physical activity to prevent and manage gestational diabetes

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618001355268
Enrollment
60
Registered
2018-08-10
Start date
2018-09-04
Completion date
2022-01-20
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This project seeks to determine the feasibility and effectiveness of postmeal walking exercise to control blood glucose in gestational diabetes. Postmeal walking involves 10 min of physical activity (preferably walking) after breakfast, lunch and dinner. Women with gestational diabetes will be randomised to standard-care alone, or with postmeal walking. It is hypothesised that postmeal walking will improves aspects of blood glucose control more than standard-care alone.

Interventions

Women between 12-30 wks of pregnancy will be advised to perform 10-minutes of light-moderate intensity walking after each main meal. They will also receive standard-care from the Diabetes Service (as below control). The intervention will be from 12-35 wks of pregnancy until brith. Accelerometers will objectively measure physical activity.

Sponsors

University of Wollongong
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Between 12-30 weeks of pregnancy.

Exclusion criteria

•<18 years of age •Contraindications to performing exercise (i.e., restrictive lung disease, Multiple gestation at risk for premature labour8) •High-risk pregnancy (i.e., twins, drug or alcohol abuse, chronic health problems, or pregnancy complications) •Women on any medication for preexisting hypertension, cardiac disease, renal disease, thyroid disease, or psychosis; and women who were currently being treated with metformin or corticosteroids.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026